Cargando…
Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway
HADH is a key enzyme in fatty acid oxidation. The aim of this study was to identify the role of HADH in gastric cancer. We analyzed the expression of HADH in 102 pairs of gastric cancer samples. Western blot analysis revealed that HADH was decreased in stage I/II gastric cancer samples compared to m...
Autores principales: | Shen, Congcong, Song, Yao-Hua, Xie, Yufeng, Wang, Xiaoxiao, Wang, Yunliang, Wang, Chao, Liu, Songbai, Xue, Sheng-Li, Li, Yangxin, Liu, Bin, Tang, Zaixiang, Chen, Weichang, Song, Jenny, Amin, Hesham M., Zhou, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652705/ https://www.ncbi.nlm.nih.gov/pubmed/29100311 http://dx.doi.org/10.18632/oncotarget.19348 |
Ejemplares similares
-
Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach
por: Wang, Xiaoxiao, et al.
Publicado: (2016) -
Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis
por: Wang, Xiaoqing, et al.
Publicado: (2022) -
HADH may be the target molecule of early vascular endothelial impairment in T2DM
por: Ye, Haowen, et al.
Publicado: (2022) -
Differentially expressed genes PCCA, ECHS1, and HADH are potential prognostic biomarkers for gastric cancer
por: Du, Zhongxiang, et al.
Publicado: (2021) -
DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)